RecruitingHepatitis BCirrhosis, LiverChronic Liver Disease
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Investigators want to compare the seroconversion rates between two-dose and three-dose regimens of the hepatitis B vaccine (Heplisav B) among patients with cirrhosis, a randomized prospective study.
Sponsor: Mercy Medical Center
You may qualify if…
- ✓ \- All the cirrhosis patients more than 18 years old presented to the hepatology clinic in Mercy Medical Center between 09/2020 and 07/2021 who do not have immunity against Hepatitis B (defined as anti-HBs titer \< 10 mIU/ml) will be recruited.
You may not qualify if…
- ✕ Anyone who has had a serious allergic reaction to a prior dose of the hepatitis B vaccine, a component of the hepatitis B vaccine, or yeast should not receive the hepatitis B vaccine.
- ✕ Those who had previous exposure to hepatitis B.
- ✕ Post liver transplant patients.
- ✕ Less than 18 years old.
Where it's recruiting
Maryland
Baltimore
Source: ClinicalTrials.gov · NCT04588077 · last updated 2024-11-19